455
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

Successful treatment of Nerium oleander toxicity with titrated Digoxin Fab antibody dosing

&
Pages 678-680 | Received 23 Nov 2017, Accepted 20 Jan 2018, Published online: 30 Jan 2018

References

  • Haynes BE, Bessen HA, Wightman WD. Oleander tea: herbal draught of death. Ann Emerg Med. 1985;14:350–353.
  • Roberts DM, Southcott E, Potter JM, et al. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal. Ther Drug Monit. 2006;28:784–792.
  • Ni D, Madden TL, Johansen M, et al. Murine pharmacokinetics and metabolism of oleandrin, a cytotoxic component of nerium oleander. J Exp Ther Oncol. 2002;2:278–285.
  • Dasgupta A, Hart AP. Rapid detection of oleander poisoning using fluorescence polarization immunoassay for digitoxin. Effect of treatment with digoxin-specific Fab antibody fragment (ovine). Am J Clin Pathol. 1997;108:411–416.
  • Eddleston M, Rajapakse S, Rajakanthan, et al. Anti-digoxin fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet. 2000;355:967–972.
  • Kirkpatrick CH. Allergic histories and reactions of patients treated with digoxin immune fab (ovine) antibody. The digibind study advisory panel. Am J Emerg Med. 1991;9(2 Suppl 1):7–10.
  • Chan BS, Isbister GK, O’Leary M, et al. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). Clin Toxicol. 2016;54:488–494.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.